5-aminoimidazole-4-carboxyamide ribonucleoside induces G 1/S arrest and nanog downregulation via p53 and enhances erythroid differentiation

Hee Don Chae, Man Ryul Lee, Hal E. Broxmeyer

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Molecular mechanisms of how energy metabolism affects embryonic stem cell (ESC) pluripotency remain unclear. AMP-activated protein kinase (AMPK), a key regulator for controlling energy metabolism, is activated in response to ATP-exhausting stress. We investigated whether cellular energy homeostasis is associated with maintenance of self-renewal and pluripotency in mouse ESCs (mESCs) by using 5-aminoimidazole-4-carboxyamide ribonucleoside (AICAR) as an activator of AMPK. We demonstrate that AICAR treatment activates the p53/p21 pathway and markedly inhibits proliferation of R1 mESCs by inducing G1/S-phase cell cycle arrest, without influencing apoptosis. Treatment with AICAR also significantly reduces pluripotent stem cell markers, Nanog and stage-specific embryonic antigen-1, in the presence of leukemia inhibitory factor, without affecting expression of Oct4. H9 human ESCs also responded to AICAR with induction of p53 activation and repression of Nanog expression. AICAR reduced Nanog mRNA levels in mESCs transiently, an effect not due to expression of miR- 134 which can suppress Nanog expression. AICAR induced Nanog degradation, an effect inhibited by MG132, a proteasome inhibitor. Although AICAR reduced embryoid body formation from mESCs, it increased expression levels of erythroid cell lineage markers (Ter119, GATA1, Klf1, Hbb-b, and Hbb-bh1). Although erythroid differentiation was enhanced by AICAR, endothelial lineage populations were remarkably reduced in AICAR-treated cells. Our results suggest that energy metabolism regulated by AMPK activity may control the balance of self-renewal and differentiation of ESCs.

Original languageEnglish (US)
Pages (from-to)140-149
Number of pages10
JournalSTEM CELLS
Volume30
Issue number2
DOIs
StatePublished - Feb 1 2012

Fingerprint

Ribonucleosides
Down-Regulation
AMP-Activated Protein Kinases
Energy Metabolism
CD15 Antigens
Embryoid Bodies
Leukemia Inhibitory Factor
4-aminoimidazole
Pluripotent Stem Cells
Erythroid Cells
Proteasome Inhibitors
G1 Phase
Cell Lineage
Embryonic Stem Cells
Cell Cycle Checkpoints
S Phase
Homeostasis
Adenosine Triphosphate
Apoptosis
Messenger RNA

Keywords

  • AICAR
  • Erythroid
  • Mouse embryonic stem cells
  • Nanog
  • P53
  • Proliferation

ASJC Scopus subject areas

  • Cell Biology
  • Developmental Biology
  • Molecular Medicine

Cite this

5-aminoimidazole-4-carboxyamide ribonucleoside induces G 1/S arrest and nanog downregulation via p53 and enhances erythroid differentiation. / Chae, Hee Don; Lee, Man Ryul; Broxmeyer, Hal E.

In: STEM CELLS, Vol. 30, No. 2, 01.02.2012, p. 140-149.

Research output: Contribution to journalArticle

@article{2d8fc8621cbd4064962356f2c66d2996,
title = "5-aminoimidazole-4-carboxyamide ribonucleoside induces G 1/S arrest and nanog downregulation via p53 and enhances erythroid differentiation",
abstract = "Molecular mechanisms of how energy metabolism affects embryonic stem cell (ESC) pluripotency remain unclear. AMP-activated protein kinase (AMPK), a key regulator for controlling energy metabolism, is activated in response to ATP-exhausting stress. We investigated whether cellular energy homeostasis is associated with maintenance of self-renewal and pluripotency in mouse ESCs (mESCs) by using 5-aminoimidazole-4-carboxyamide ribonucleoside (AICAR) as an activator of AMPK. We demonstrate that AICAR treatment activates the p53/p21 pathway and markedly inhibits proliferation of R1 mESCs by inducing G1/S-phase cell cycle arrest, without influencing apoptosis. Treatment with AICAR also significantly reduces pluripotent stem cell markers, Nanog and stage-specific embryonic antigen-1, in the presence of leukemia inhibitory factor, without affecting expression of Oct4. H9 human ESCs also responded to AICAR with induction of p53 activation and repression of Nanog expression. AICAR reduced Nanog mRNA levels in mESCs transiently, an effect not due to expression of miR- 134 which can suppress Nanog expression. AICAR induced Nanog degradation, an effect inhibited by MG132, a proteasome inhibitor. Although AICAR reduced embryoid body formation from mESCs, it increased expression levels of erythroid cell lineage markers (Ter119, GATA1, Klf1, Hbb-b, and Hbb-bh1). Although erythroid differentiation was enhanced by AICAR, endothelial lineage populations were remarkably reduced in AICAR-treated cells. Our results suggest that energy metabolism regulated by AMPK activity may control the balance of self-renewal and differentiation of ESCs.",
keywords = "AICAR, Erythroid, Mouse embryonic stem cells, Nanog, P53, Proliferation",
author = "Chae, {Hee Don} and Lee, {Man Ryul} and Broxmeyer, {Hal E.}",
year = "2012",
month = "2",
day = "1",
doi = "10.1002/stem.778",
language = "English (US)",
volume = "30",
pages = "140--149",
journal = "Stem Cells",
issn = "1066-5099",
publisher = "AlphaMed Press",
number = "2",

}

TY - JOUR

T1 - 5-aminoimidazole-4-carboxyamide ribonucleoside induces G 1/S arrest and nanog downregulation via p53 and enhances erythroid differentiation

AU - Chae, Hee Don

AU - Lee, Man Ryul

AU - Broxmeyer, Hal E.

PY - 2012/2/1

Y1 - 2012/2/1

N2 - Molecular mechanisms of how energy metabolism affects embryonic stem cell (ESC) pluripotency remain unclear. AMP-activated protein kinase (AMPK), a key regulator for controlling energy metabolism, is activated in response to ATP-exhausting stress. We investigated whether cellular energy homeostasis is associated with maintenance of self-renewal and pluripotency in mouse ESCs (mESCs) by using 5-aminoimidazole-4-carboxyamide ribonucleoside (AICAR) as an activator of AMPK. We demonstrate that AICAR treatment activates the p53/p21 pathway and markedly inhibits proliferation of R1 mESCs by inducing G1/S-phase cell cycle arrest, without influencing apoptosis. Treatment with AICAR also significantly reduces pluripotent stem cell markers, Nanog and stage-specific embryonic antigen-1, in the presence of leukemia inhibitory factor, without affecting expression of Oct4. H9 human ESCs also responded to AICAR with induction of p53 activation and repression of Nanog expression. AICAR reduced Nanog mRNA levels in mESCs transiently, an effect not due to expression of miR- 134 which can suppress Nanog expression. AICAR induced Nanog degradation, an effect inhibited by MG132, a proteasome inhibitor. Although AICAR reduced embryoid body formation from mESCs, it increased expression levels of erythroid cell lineage markers (Ter119, GATA1, Klf1, Hbb-b, and Hbb-bh1). Although erythroid differentiation was enhanced by AICAR, endothelial lineage populations were remarkably reduced in AICAR-treated cells. Our results suggest that energy metabolism regulated by AMPK activity may control the balance of self-renewal and differentiation of ESCs.

AB - Molecular mechanisms of how energy metabolism affects embryonic stem cell (ESC) pluripotency remain unclear. AMP-activated protein kinase (AMPK), a key regulator for controlling energy metabolism, is activated in response to ATP-exhausting stress. We investigated whether cellular energy homeostasis is associated with maintenance of self-renewal and pluripotency in mouse ESCs (mESCs) by using 5-aminoimidazole-4-carboxyamide ribonucleoside (AICAR) as an activator of AMPK. We demonstrate that AICAR treatment activates the p53/p21 pathway and markedly inhibits proliferation of R1 mESCs by inducing G1/S-phase cell cycle arrest, without influencing apoptosis. Treatment with AICAR also significantly reduces pluripotent stem cell markers, Nanog and stage-specific embryonic antigen-1, in the presence of leukemia inhibitory factor, without affecting expression of Oct4. H9 human ESCs also responded to AICAR with induction of p53 activation and repression of Nanog expression. AICAR reduced Nanog mRNA levels in mESCs transiently, an effect not due to expression of miR- 134 which can suppress Nanog expression. AICAR induced Nanog degradation, an effect inhibited by MG132, a proteasome inhibitor. Although AICAR reduced embryoid body formation from mESCs, it increased expression levels of erythroid cell lineage markers (Ter119, GATA1, Klf1, Hbb-b, and Hbb-bh1). Although erythroid differentiation was enhanced by AICAR, endothelial lineage populations were remarkably reduced in AICAR-treated cells. Our results suggest that energy metabolism regulated by AMPK activity may control the balance of self-renewal and differentiation of ESCs.

KW - AICAR

KW - Erythroid

KW - Mouse embryonic stem cells

KW - Nanog

KW - P53

KW - Proliferation

UR - http://www.scopus.com/inward/record.url?scp=84862907953&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862907953&partnerID=8YFLogxK

U2 - 10.1002/stem.778

DO - 10.1002/stem.778

M3 - Article

C2 - 22076938

AN - SCOPUS:84862907953

VL - 30

SP - 140

EP - 149

JO - Stem Cells

JF - Stem Cells

SN - 1066-5099

IS - 2

ER -